Literature DB >> 22190394

HAVCR1 gene haplotypes and infection by different viral hepatitis C virus genotypes.

Cristina Abad-Molina1, José-Raúl Garcia-Lozano, Marco-Antonio Montes-Cano, Almudena Torres-Cornejo, Fuensanta Torrecillas, José Aguilar-Reina, Manuel Romero-Gómez, Luis-Fernando López-Cortés, Antonio Núñez-Roldan, María-Francisca González-Escribano.   

Abstract

The hepatitis A virus cellular receptor 1 (HAVCR1) gene is highly polymorphic, and several variants have been associated with susceptibility to allergic and autoimmune diseases. The HAVCR1 gene region was identified as a candidate for hepatitis C virus (HCV) natural clearance in a genotyping study of selected immune response genes in both European-American and African-American populations. The aim of the present study was to explore the influence of HAVCR1 in the outcome of HCV infection in the Spanish population. Three cohorts, consisting of 354 subjects with persistent HCV infection (285 with persistent HCV monoinfection and 69 with natural clearance), 182 coinfected HIV/HCV patients, and 320 controls, were included. Samples were genotyped in several polymorphic positions, insertion/deletion variants in exon 4 and tag single nucleotide polymorphisms (SNPs), in order to define previously described HAVCR1 haplotypes (haplotypes A to D). No statistically significant differences were observed with spontaneous resolution of infection or with viral clearance after treatment. Nevertheless, different rates of infection by viral genotypes (G's) were observed among the HAVCR1 haplotypes. Individuals bearing haplotype C had the highest viral G1 infection rate when compared to individuals bearing other haplotypes (75.82% versus 57.72%, respectively; corrected P value [P(c)], 3.2 × 10(-4); odds ratio [OR], 2.30; 95% confidence interval [CI], 1.51 to 3.47). Thus, HAVCR1 could be involved in susceptibility or resistance to infection by a particular HCV genotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22190394      PMCID: PMC3272938          DOI: 10.1128/CVI.05305-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  29 in total

1.  TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation.

Authors:  Jennifer Hartt Meyers; Sumone Chakravarti; David Schlesinger; Zsolt Illes; Hanspeter Waldner; Sarah E Umetsu; James Kenny; Xin Xiao Zheng; Dale T Umetsu; Rosemarie H DeKruyff; Terry B Strom; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

2.  TIM-1 induces T cell activation and inhibits the development of peripheral tolerance.

Authors:  Sarah E Umetsu; Wan-Ling Lee; Jennifer J McIntire; Laura Downey; Bharati Sanjanwala; Omid Akbari; Gerald J Berry; Haruo Nagumo; Gordon J Freeman; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Nat Immunol       Date:  2005-03-27       Impact factor: 25.606

3.  TIM-1 signaling in B cells regulates antibody production.

Authors:  Juan Ma; Yoshihiko Usui; Kazuyoshi Takeda; Norihiro Harada; Hideo Yagita; Ko Okumura; Hisaya Akiba
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

Review 4.  Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.

Authors:  Peter Simmonds; Jens Bukh; Christophe Combet; Gilbert Deléage; Nobuyuki Enomoto; Stephen Feinstone; Phillippe Halfon; Geneviève Inchauspé; Carla Kuiken; Geert Maertens; Masashi Mizokami; Donald G Murphy; Hiroaki Okamoto; Jean-Michel Pawlotsky; François Penin; Erwin Sablon; Tadasu Shin-I; Lieven J Stuyver; Heinz-Jürgen Thiel; Sergei Viazov; Amy J Weiner; Anders Widell
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family.

Authors:  J J McIntire; S E Umetsu; O Akbari; M Potter; V K Kuchroo; G S Barsh; G J Freeman; D T Umetsu; R H DeKruyff
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

6.  Evidence for natural selection in the HAVCR1 gene: high degree of amino-acid variability in the mucin domain of human HAVCR1 protein.

Authors:  T Nakajima; S Wooding; Y Satta; N Jinnai; S Goto; I Hayasaka; N Saitou; J Guan-Jun; K Tokunaga; L B Jorde; M Emi; I Inoue
Journal:  Genes Immun       Date:  2005-08       Impact factor: 2.676

7.  Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus.

Authors:  G Kaplan; A Totsuka; P Thompson; T Akatsuka; Y Moritsugu; S M Feinstone
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

Review 8.  Natural history of hepatitis C.

Authors:  David L Thomas; Leonard B Seeff
Journal:  Clin Liver Dis       Date:  2005-08       Impact factor: 6.126

9.  The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor.

Authors:  D Feigelstock; P Thompson; P Mattoo; Y Zhang; G G Kaplan
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family.

Authors:  César Santiago; Angela Ballesteros; Cecilia Tami; Laura Martínez-Muñoz; Gerardo G Kaplan; José M Casasnovas
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

View more
  5 in total

1.  Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans.

Authors:  Genevieve Wojcik; Rachel Latanich; Tim Mosbruger; Jacquie Astemborski; Gregory D Kirk; Shruti H Mehta; James J Goedert; Arthur Y Kim; Eric C Seaberg; Michael Busch; David L Thomas; Priya Duggal; Chloe L Thio
Journal:  J Infect Dis       Date:  2013-08-20       Impact factor: 5.226

2.  A multifaceted computational report on the variants effect on KIR2DL3 and IFNL3 candidate gene in HCV clearance.

Authors:  Pratichi Singh; J Febin Prabhu Dass
Journal:  Mol Biol Rep       Date:  2016-07-26       Impact factor: 2.316

3.  Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.

Authors:  Alla Kachko; Maria Isabel Costafreda; Iryna Zubkova; Jerome Jacques; Kazuyo Takeda; Frances Wells; Gerardo Kaplan; Marian E Major
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

4.  TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection.

Authors:  Jing Wang; Luhua Qiao; Zhouhua Hou; Guangxiang Luo
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.

Authors:  Kristi Huik; Radko Avi; Merit Pauskar; Eveli Kallas; Ene-Ly Jõgeda; Tõnis Karki; Kristi Rüütel; Ave Talu; Katri Abel-Ollo; Anneli Uusküla; Andrew Carrillo; Sunil K Ahuja; Weijing He; Irja Lutsar
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.